| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| CVS - CVS Health Corp | HOLD | 0 @ USD 64.26 | USD 0 | The current share valuation price of CVS based on adjusted close was USD 64.26. The average price that CVS shares were previous bought at was USD 62.9223. The current market price is 2.1% higher than average price they were purchased at. The value of the holding in CVS has increased by USD 237,299 compared to the previous valuation of CVS Health Corp however if the holding was sold on 2025-06-10 this would crystalise an overall loss. |
| DVA - DaVita HealthCare Partners Inc | SELL | -50 @ USD 139.11 | USD -6,956 | The ETF sold 50 shares of DVA on 2025-06-10. The shares were previously bought for an average price of USD 154.347. The DaVita HealthCare Partners Inc shares were sold for -9.9% lower than average price of previous purchases. This resulted in an overall loss of USD 762 The average price that the ETF previously sold DVA share for is USD 153.024 which is higher than the selling price of USD 139.11 on 2025-06-10. |
| CRL - Creightons Plc | SELL | -56 @ USD 151 | USD -8,456 | The ETF sold 56 shares of CRL on 2025-06-10. The shares were previously bought for an average price of USD 168.232. The Creightons Plc shares were sold for -10.2% lower than average price of previous purchases. This resulted in an overall loss of USD 965 The average price that the ETF previously sold CRL share for is USD 187.003 which is higher than the selling price of USD 151 on 2025-06-10. |
| TECH - Bio-Techne Corp | SELL | -174 @ USD 51.4 | USD -8,944 | The ETF sold 174 shares of TECH on 2025-06-10. The shares were previously bought for an average price of USD 65.0058. The Bio-Techne Corp shares were sold for -20.9% lower than average price of previous purchases. This resulted in an overall loss of USD 2,367 The average price that the ETF previously sold TECH share for is USD 69.8088 which is higher than the selling price of USD 51.4 on 2025-06-10. |
| HSIC - Henry Schein Inc | SELL | -138 @ USD 71.37 | USD -9,849 | The ETF sold 138 shares of HSIC on 2025-06-10. The shares were previously bought for an average price of USD 72.8322. The Henry Schein Inc shares were sold for -2.0% lower than average price of previous purchases. This resulted in an overall loss of USD 202 The average price that the ETF previously sold HSIC share for is USD 71.1208 so the ETF has sold 138 shares on 2025-06-10 at a higher price than the previous selling average. |
| MRNA - Moderna Inc | SELL | -368 @ USD 27.68 | USD -10,186 | The ETF sold 368 shares of MRNA on 2025-06-10. The shares were previously bought for an average price of USD 35.3915. The Moderna Inc shares were sold for -21.8% lower than average price of previous purchases. This resulted in an overall loss of USD 2,838 The average price that the ETF previously sold MRNA share for is USD 41.0688 which is higher than the selling price of USD 27.68 on 2025-06-10. |
| UHS - Universal Health Services Inc | SELL | -62 @ USD 172.67 | USD -10,706 | The ETF sold 62 shares of UHS on 2025-06-10. The shares were previously bought for an average price of USD 189.072. The Universal Health Services Inc shares were sold for -8.7% lower than average price of previous purchases. This resulted in an overall loss of USD 1,017 The average price that the ETF previously sold UHS share for is USD 192.459 which is higher than the selling price of USD 172.67 on 2025-06-10. |
| SOLV - Solventum Corp. | SELL | -148 @ USD 75.55 | USD -11,181 | The ETF sold 148 shares of SOLV on 2025-06-10. The shares were previously bought for an average price of USD 74.1474. The Solventum Corp. shares were sold for 1.9% higher than average price of previous purchases. This sale made a profit of USD 208 The average price that the ETF previously sold SOLV share for is USD 70.3881 so the ETF has sold 148 shares on 2025-06-10 at a higher price than the previous selling average. |
| VTRS - Viatris Inc | SELL | -1,336 @ USD 9.04 | USD -12,077 | The ETF sold 1336 shares of VTRS on 2025-06-10. The shares were previously bought for an average price of USD 10.3985. The Viatris Inc shares were sold for -13.1% lower than average price of previous purchases. This resulted in an overall loss of USD 1,815 The average price that the ETF previously sold VTRS share for is USD 12.009 which is higher than the selling price of USD 9.04 on 2025-06-10. |
| INCY - Incyte Corporation | SELL | -178 @ USD 70.07 | USD -12,472 | The ETF sold 178 shares of INCY on 2025-06-10. The shares were previously bought for an average price of USD 69.0067. The Incyte Corporation shares were sold for 1.5% higher than average price of previous purchases. This sale made a profit of USD 189 The average price that the ETF previously sold INCY share for is USD 72.2843 which is higher than the selling price of USD 70.07 on 2025-06-10. |
| RVTY - Revvity Inc. | SELL | -136 @ USD 96.25 | USD -13,090 | The ETF sold 136 shares of RVTY on 2025-06-10. The shares were previously bought for an average price of USD 111.979. The Revvity Inc. shares were sold for -14.0% lower than average price of previous purchases. This resulted in an overall loss of USD 2,139 The average price that the ETF previously sold RVTY share for is USD 113.066 which is higher than the selling price of USD 96.25 on 2025-06-10. |
| ALGN - Align Technology Inc | SELL | -78 @ USD 188.07 | USD -14,669 | The ETF sold 78 shares of ALGN on 2025-06-10. The shares were previously bought for an average price of USD 188.268. The Align Technology Inc shares were sold for -0.1% lower than average price of previous purchases. This resulted in an overall loss of USD 15 The average price that the ETF previously sold ALGN share for is USD 213.854 which is higher than the selling price of USD 188.07 on 2025-06-10. |
| HOLX - Hologic Inc | SELL | -248 @ USD 65.14 | USD -16,155 | The ETF sold 248 shares of HOLX on 2025-06-10. The shares were previously bought for an average price of USD 66.9002. The Hologic Inc shares were sold for -2.6% lower than average price of previous purchases. This resulted in an overall loss of USD 437 The average price that the ETF previously sold HOLX share for is USD 71.7796 which is higher than the selling price of USD 65.14 on 2025-06-10. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -224 @ USD 72.69 | USD -16,283 | The ETF sold 224 shares of COO on 2025-06-10. The shares were previously bought for an average price of USD 89.0886. The The Cooper Companies, Inc. Common Stock shares were sold for -18.4% lower than average price of previous purchases. This resulted in an overall loss of USD 3,673 The average price that the ETF previously sold COO share for is USD 95.2993 which is higher than the selling price of USD 72.69 on 2025-06-10. |
| MOH - MOH | SELL | -60 @ USD 295.69 | USD -17,741 | The ETF sold 60 shares of MOH on 2025-06-10. The shares were previously bought for an average price of USD 309.477. The MOH shares were sold for -4.5% lower than average price of previous purchases. This resulted in an overall loss of USD 827 The average price that the ETF previously sold MOH share for is USD 306.642 which is higher than the selling price of USD 295.69 on 2025-06-10. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -60 @ USD 295.69 | USD -17,741 | The ETF sold 60 shares of MOH on 2025-06-10. The shares were previously bought for an average price of USD 309.477. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for -4.5% lower than average price of previous purchases. This resulted in an overall loss of USD 827 The average price that the ETF previously sold MOH share for is USD 306.642 which is higher than the selling price of USD 295.69 on 2025-06-10. |
| WST - West Pharmaceutical Services Inc | SELL | -78 @ USD 227.7 | USD -17,761 | The ETF sold 78 shares of WST on 2025-06-10. The shares were previously bought for an average price of USD 256.3. The West Pharmaceutical Services Inc shares were sold for -11.2% lower than average price of previous purchases. This resulted in an overall loss of USD 2,231 The average price that the ETF previously sold WST share for is USD 300.974 which is higher than the selling price of USD 227.7 on 2025-06-10. |
| BAX - Baxter International Inc | SELL | -560 @ USD 31.72 | USD -17,763 | The ETF sold 560 shares of BAX on 2025-06-10. The shares were previously bought for an average price of USD 33.3208. The Baxter International Inc shares were sold for -4.8% lower than average price of previous purchases. This resulted in an overall loss of USD 896 The average price that the ETF previously sold BAX share for is USD 32.3711 which is higher than the selling price of USD 31.72 on 2025-06-10. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -218 @ USD 94.92 | USD -20,693 | The ETF sold 218 shares of ZBH on 2025-06-10. The shares were previously bought for an average price of USD 107.101. The Zimmer Biomet Holdings Inc shares were sold for -11.4% lower than average price of previous purchases. This resulted in an overall loss of USD 2,655 The average price that the ETF previously sold ZBH share for is USD 106.852 which is higher than the selling price of USD 94.92 on 2025-06-10. |
| BIIB - Biogen Inc | SELL | -160 @ USD 135.49 | USD -21,678 | The ETF sold 160 shares of BIIB on 2025-06-10. The shares were previously bought for an average price of USD 145.643. The Biogen Inc shares were sold for -7.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,624 The average price that the ETF previously sold BIIB share for is USD 156.598 which is higher than the selling price of USD 135.49 on 2025-06-10. |
| DGX - Quest Diagnostics Incorporated | SELL | -124 @ USD 177.44 | USD -22,003 | The ETF sold 124 shares of DGX on 2025-06-10. The shares were previously bought for an average price of USD 167.015. The Quest Diagnostics Incorporated shares were sold for 6.2% higher than average price of previous purchases. This sale made a profit of USD 1,293 The average price that the ETF previously sold DGX share for is USD 160.185 so the ETF has sold 124 shares on 2025-06-10 at a higher price than the previous selling average. |
| WAT - Waters Corporation | SELL | -64 @ USD 349.84 | USD -22,390 | The ETF sold 64 shares of WAT on 2025-06-10. The shares were previously bought for an average price of USD 369.261. The Waters Corporation shares were sold for -5.3% lower than average price of previous purchases. This resulted in an overall loss of USD 1,243 The average price that the ETF previously sold WAT share for is USD 371.562 which is higher than the selling price of USD 349.84 on 2025-06-10. |
| WAT - MULETFWATIMETFP | SELL | -64 @ USD 349.84 | USD -22,390 | The ETF sold 64 shares of WAT on 2025-06-10. The shares were previously bought for an average price of USD 369.261. The MULETFWATIMETFP shares were sold for -5.3% lower than average price of previous purchases. This resulted in an overall loss of USD 1,243 The average price that the ETF previously sold WAT share for is USD 371.562 which is higher than the selling price of USD 349.84 on 2025-06-10. |
| PODD - Insulet Corporation | SELL | -76 @ USD 298.73 | USD -22,703 | The ETF sold 76 shares of PODD on 2025-06-10. The shares were previously bought for an average price of USD 268.184. The Insulet Corporation shares were sold for 11.4% higher than average price of previous purchases. This sale made a profit of USD 2,321 The average price that the ETF previously sold PODD share for is USD 264.815 so the ETF has sold 76 shares on 2025-06-10 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -90 @ USD 259.37 | USD -23,343 | The ETF sold 90 shares of LH on 2025-06-10. The shares were previously bought for an average price of USD 241.284. The Laboratory Corporation of America Holdings shares were sold for 7.5% higher than average price of previous purchases. This sale made a profit of USD 1,628 The average price that the ETF previously sold LH share for is USD 236.572 so the ETF has sold 90 shares on 2025-06-10 at a higher price than the previous selling average. |
| STE - STERIS plc | SELL | -110 @ USD 242.36 | USD -26,660 | The ETF sold 110 shares of STE on 2025-06-10. The shares were previously bought for an average price of USD 222.089. The STERIS plc shares were sold for 9.1% higher than average price of previous purchases. This sale made a profit of USD 2,230 The average price that the ETF previously sold STE share for is USD 216.538 so the ETF has sold 110 shares on 2025-06-10 at a higher price than the previous selling average. |
| MTD - Mettler-Toledo International Inc | SELL | -22 @ USD 1216.57 | USD -26,765 | The ETF sold 22 shares of MTD on 2025-06-10. The shares were previously bought for an average price of USD 1239.38. The Mettler-Toledo International Inc shares were sold for -1.8% lower than average price of previous purchases. This resulted in an overall loss of USD 502 The average price that the ETF previously sold MTD share for is USD 1236.38 which is higher than the selling price of USD 1216.57 on 2025-06-10. |
| MTD - AMUNDI EUR GOV 710 | SELL | -22 @ USD 1216.57 | USD -26,765 | The ETF sold 22 shares of MTD on 2025-06-10. The shares were previously bought for an average price of USD 1239.38. The AMUNDI EUR GOV 710 shares were sold for -1.8% lower than average price of previous purchases. This resulted in an overall loss of USD 502 The average price that the ETF previously sold MTD share for is USD 1236.38 which is higher than the selling price of USD 1216.57 on 2025-06-10. |
| IQV - IQVIA Holdings Inc | SELL | -184 @ USD 159.77 | USD -29,398 | The ETF sold 184 shares of IQV on 2025-06-10. The shares were previously bought for an average price of USD 191.616. The IQVIA Holdings Inc shares were sold for -16.6% lower than average price of previous purchases. This resulted in an overall loss of USD 5,860 The average price that the ETF previously sold IQV share for is USD 195.461 which is higher than the selling price of USD 159.77 on 2025-06-10. |
| HUM - Hummingbird Resources PLC | SELL | -132 @ USD 231.98 | USD -30,621 | The ETF sold 132 shares of HUM on 2025-06-10. The shares were previously bought for an average price of USD 270.038. The Hummingbird Resources PLC shares were sold for -14.1% lower than average price of previous purchases. This resulted in an overall loss of USD 5,024 The average price that the ETF previously sold HUM share for is USD 275.661 which is higher than the selling price of USD 231.98 on 2025-06-10. |
| HUM - Humana Inc | SELL | -132 @ USD 231.98 | USD -30,621 | The ETF sold 132 shares of HUM on 2025-06-10. The shares were previously bought for an average price of USD 270.038. The Humana Inc shares were sold for -14.1% lower than average price of previous purchases. This resulted in an overall loss of USD 5,024 The average price that the ETF previously sold HUM share for is USD 275.661 which is higher than the selling price of USD 231.98 on 2025-06-10. |
| CNC - Concurrent Technologies Plc | SELL | -552 @ USD 55.51 | USD -30,642 | The ETF sold 552 shares of CNC on 2025-06-10. The shares were previously bought for an average price of USD 60.1182. The Concurrent Technologies Plc shares were sold for -7.7% lower than average price of previous purchases. This resulted in an overall loss of USD 2,544 The average price that the ETF previously sold CNC share for is USD 60.0255 which is higher than the selling price of USD 55.51 on 2025-06-10. |
| DXCM - DexCom Inc | SELL | -434 @ USD 84.82 | USD -36,812 | The ETF sold 434 shares of DXCM on 2025-06-10. The shares were previously bought for an average price of USD 77.8843. The DexCom Inc shares were sold for 8.9% higher than average price of previous purchases. This sale made a profit of USD 3,010 The average price that the ETF previously sold DXCM share for is USD 75.9623 so the ETF has sold 434 shares on 2025-06-10 at a higher price than the previous selling average. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -502 @ USD 73.92 | USD -37,108 | The ETF sold 502 shares of GEHC on 2025-06-10. The shares were previously bought for an average price of USD 84.8343. The GE HealthCare Technologies Inc. shares were sold for -12.9% lower than average price of previous purchases. This resulted in an overall loss of USD 5,479 The average price that the ETF previously sold GEHC share for is USD 80.8324 which is higher than the selling price of USD 73.92 on 2025-06-10. |
| A - Agilent Technologies Inc | SELL | -314 @ USD 120.52 | USD -37,843 | The ETF sold 314 shares of A on 2025-06-10. The shares were previously bought for an average price of USD 128.911. The Agilent Technologies Inc shares were sold for -6.5% lower than average price of previous purchases. This resulted in an overall loss of USD 2,635 The average price that the ETF previously sold A share for is USD 131.833 which is higher than the selling price of USD 120.52 on 2025-06-10. |
| RMD - ResMed Inc | SELL | -162 @ USD 252.66 | USD -40,931 | The ETF sold 162 shares of RMD on 2025-06-10. The shares were previously bought for an average price of USD 234.22. The ResMed Inc shares were sold for 7.9% higher than average price of previous purchases. This sale made a profit of USD 2,987 The average price that the ETF previously sold RMD share for is USD 240.375 so the ETF has sold 162 shares on 2025-06-10 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -268 @ USD 153.08 | USD -41,025 | The ETF sold 268 shares of CAH on 2025-06-10. The shares were previously bought for an average price of USD 128.331. The Cardinal Health Inc shares were sold for 19.3% higher than average price of previous purchases. This sale made a profit of USD 6,633 The average price that the ETF previously sold CAH share for is USD 123.644 so the ETF has sold 268 shares on 2025-06-10 at a higher price than the previous selling average. |
| IDXX - IDEXX Laboratories Inc | SELL | -88 @ USD 525.93 | USD -46,282 | The ETF sold 88 shares of IDXX on 2025-06-10. The shares were previously bought for an average price of USD 440.802. The IDEXX Laboratories Inc shares were sold for 19.3% higher than average price of previous purchases. This sale made a profit of USD 7,491 The average price that the ETF previously sold IDXX share for is USD 430.818 so the ETF has sold 88 shares on 2025-06-10 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -652 @ USD 75.8 | USD -49,422 | The ETF sold 652 shares of EW on 2025-06-10. The shares were previously bought for an average price of USD 71.2794. The Edwards Lifesciences Corp shares were sold for 6.3% higher than average price of previous purchases. This sale made a profit of USD 2,947 The average price that the ETF previously sold EW share for is USD 70.5664 so the ETF has sold 652 shares on 2025-06-10 at a higher price than the previous selling average. |
| COR - Cencora Inc. | SELL | -190 @ USD 284.24 | USD -54,006 | The ETF sold 190 shares of COR on 2025-06-10. The shares were previously bought for an average price of USD 254.646. The Cencora Inc. shares were sold for 11.6% higher than average price of previous purchases. This sale made a profit of USD 5,623 The average price that the ETF previously sold COR share for is USD 247.788 so the ETF has sold 190 shares on 2025-06-10 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -318 @ USD 174.39 | USD -55,456 | The ETF sold 318 shares of BDX on 2025-06-10. The shares were previously bought for an average price of USD 226.588. The Becton Dickinson and Company shares were sold for -23.0% lower than average price of previous purchases. This resulted in an overall loss of USD 16,599 The average price that the ETF previously sold BDX share for is USD 221.695 which is higher than the selling price of USD 174.39 on 2025-06-10. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -116 @ USD 523.53 | USD -60,729 | The ETF sold 116 shares of REGN on 2025-06-10. The shares were previously bought for an average price of USD 704.506. The Regeneron Pharmaceuticals Inc shares were sold for -25.7% lower than average price of previous purchases. This resulted in an overall loss of USD 20,993 The average price that the ETF previously sold REGN share for is USD 742.028 which is higher than the selling price of USD 523.53 on 2025-06-10. |
| HCA - HCA Holdings Inc | SELL | -196 @ USD 364.92 | USD -71,524 | The ETF sold 196 shares of HCA on 2025-06-10. The shares were previously bought for an average price of USD 337.989. The HCA Holdings Inc shares were sold for 8.0% higher than average price of previous purchases. This sale made a profit of USD 5,278 The average price that the ETF previously sold HCA share for is USD 328.9 so the ETF has sold 196 shares on 2025-06-10 at a higher price than the previous selling average. |
| ZTS - Zoetis Inc | SELL | -494 @ USD 167.1 | USD -82,547 | The ETF sold 494 shares of ZTS on 2025-06-10. The shares were previously bought for an average price of USD 167.219. The Zoetis Inc shares were sold for -0.1% lower than average price of previous purchases. This resulted in an overall loss of USD 59 The average price that the ETF previously sold ZTS share for is USD 171.258 which is higher than the selling price of USD 167.1 on 2025-06-10. |
| CI - Cigna Corp | SELL | -300 @ USD 313.62 | USD -94,086 | The ETF sold 300 shares of CI on 2025-06-10. The shares were previously bought for an average price of USD 316.767. The Cigna Corp shares were sold for -1.0% lower than average price of previous purchases. This resulted in an overall loss of USD 944 The average price that the ETF previously sold CI share for is USD 312.861 so the ETF has sold 300 shares on 2025-06-10 at a higher price than the previous selling average. |
| MCK - McKesson Corporation | SELL | -138 @ USD 704.86 | USD -97,271 | The ETF sold 138 shares of MCK on 2025-06-10. The shares were previously bought for an average price of USD 621.578. The McKesson Corporation shares were sold for 13.4% higher than average price of previous purchases. This sale made a profit of USD 11,493 The average price that the ETF previously sold MCK share for is USD 606.052 so the ETF has sold 138 shares on 2025-06-10 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -254 @ USD 383.92 | USD -97,516 | The ETF sold 254 shares of ELV on 2025-06-10. The shares were previously bought for an average price of USD 410.75. The Elevance Health Inc shares were sold for -6.5% lower than average price of previous purchases. This resulted in an overall loss of USD 6,815 The average price that the ETF previously sold ELV share for is USD 401.678 which is higher than the selling price of USD 383.92 on 2025-06-10. |
| ELV - Elevance Health Inc | SELL | -254 @ USD 383.92 | USD -97,516 | The ETF sold 254 shares of ELV on 2025-06-10. The shares were previously bought for an average price of USD 410.75. The Elevance Health Inc shares were sold for -6.5% lower than average price of previous purchases. This resulted in an overall loss of USD 6,815 The average price that the ETF previously sold ELV share for is USD 401.678 which is higher than the selling price of USD 383.92 on 2025-06-10. |
| BMY - Bloomsbury Publishing Plc | SELL | -2,244 @ USD 49.97 | USD -112,133 | The ETF sold 2244 shares of BMY on 2025-06-10. The shares were previously bought for an average price of USD 57.3147. The Bloomsbury Publishing Plc shares were sold for -12.8% lower than average price of previous purchases. This resulted in an overall loss of USD 16,482 The average price that the ETF previously sold BMY share for is USD 56.1387 which is higher than the selling price of USD 49.97 on 2025-06-10. |
| MDT - Medtronic PLC | SELL | -1,416 @ USD 87.96 | USD -124,551 | The ETF sold 1416 shares of MDT on 2025-06-10. The shares were previously bought for an average price of USD 88.7467. The Medtronic PLC shares were sold for -0.9% lower than average price of previous purchases. This resulted in an overall loss of USD 1,114 The average price that the ETF previously sold MDT share for is USD 85.4231 so the ETF has sold 1416 shares on 2025-06-10 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -282 @ USD 451.52 | USD -127,329 | The ETF sold 282 shares of VRTX on 2025-06-10. The shares were previously bought for an average price of USD 478.652. The Vertex Pharmaceuticals Inc shares were sold for -5.7% lower than average price of previous purchases. This resulted in an overall loss of USD 7,651 The average price that the ETF previously sold VRTX share for is USD 462.899 which is higher than the selling price of USD 451.52 on 2025-06-10. |
| DHR - Danaher Corporation | SELL | -706 @ USD 202.62 | USD -143,050 | The ETF sold 706 shares of DHR on 2025-06-10. The shares were previously bought for an average price of USD 216.682. The Danaher Corporation shares were sold for -6.5% lower than average price of previous purchases. This resulted in an overall loss of USD 9,928 The average price that the ETF previously sold DHR share for is USD 229.932 which is higher than the selling price of USD 202.62 on 2025-06-10. |
| DHR - Danaher Corporation | SELL | -706 @ USD 202.62 | USD -143,050 | The ETF sold 706 shares of DHR on 2025-06-10. The shares were previously bought for an average price of USD 216.682. The Danaher Corporation shares were sold for -6.5% lower than average price of previous purchases. This resulted in an overall loss of USD 9,928 The average price that the ETF previously sold DHR share for is USD 229.932 which is higher than the selling price of USD 202.62 on 2025-06-10. |
| SYK - Stryker Corporation | SELL | -378 @ USD 385.05 | USD -145,549 | The ETF sold 378 shares of SYK on 2025-06-10. The shares were previously bought for an average price of USD 379.729. The Stryker Corporation shares were sold for 1.4% higher than average price of previous purchases. This sale made a profit of USD 2,011 The average price that the ETF previously sold SYK share for is USD 375.286 so the ETF has sold 378 shares on 2025-06-10 at a higher price than the previous selling average. |
| GILD - Guild Esports Plc | SELL | -1,378 @ USD 110.09 | USD -151,704 | The ETF sold 1378 shares of GILD on 2025-06-10. The shares were previously bought for an average price of USD 102.991. The Guild Esports Plc shares were sold for 6.9% higher than average price of previous purchases. This sale made a profit of USD 9,782 The average price that the ETF previously sold GILD share for is USD 94.991 so the ETF has sold 1378 shares on 2025-06-10 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -6,266 @ USD 24.3 | USD -152,264 | The ETF sold 6266 shares of PFE on 2025-06-10. The shares were previously bought for an average price of USD 25.8066. The Pfizer Inc shares were sold for -5.8% lower than average price of previous purchases. This resulted in an overall loss of USD 9,440 The average price that the ETF previously sold PFE share for is USD 25.8331 which is higher than the selling price of USD 24.3 on 2025-06-10. |
| BSX - Boston Scientific Corporation | SELL | -1,628 @ USD 99.34 | USD -161,726 | The ETF sold 1628 shares of BSX on 2025-06-10. The shares were previously bought for an average price of USD 98.6851. The Boston Scientific Corporation shares were sold for 0.7% higher than average price of previous purchases. This sale made a profit of USD 1,066 The average price that the ETF previously sold BSX share for is USD 91.0044 so the ETF has sold 1628 shares on 2025-06-10 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -1,628 @ USD 99.34 | USD -161,726 | The ETF sold 1628 shares of BSX on 2025-06-10. The shares were previously bought for an average price of USD 98.6851. The MULSTRXSSXIMETFP shares were sold for 0.7% higher than average price of previous purchases. This sale made a profit of USD 1,066 The average price that the ETF previously sold BSX share for is USD 91.0044 so the ETF has sold 1628 shares on 2025-06-10 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -592 @ USD 293.43 | USD -173,711 | The ETF sold 592 shares of AMGN on 2025-06-10. The shares were previously bought for an average price of USD 303.22. The Amgen Inc shares were sold for -3.2% lower than average price of previous purchases. This resulted in an overall loss of USD 5,796 The average price that the ETF previously sold AMGN share for is USD 288.818 so the ETF has sold 592 shares on 2025-06-10 at a higher price than the previous selling average. |
| TMO - Time Out Group plc | SELL | -422 @ USD 414.54 | USD -174,936 | The ETF sold 422 shares of TMO on 2025-06-10. The shares were previously bought for an average price of USD 521.751. The Time Out Group plc shares were sold for -20.5% lower than average price of previous purchases. This resulted in an overall loss of USD 45,243 The average price that the ETF previously sold TMO share for is USD 517.331 which is higher than the selling price of USD 414.54 on 2025-06-10. |
| ISRG - Intuitive Surgical Inc | SELL | -392 @ USD 529.6 | USD -207,603 | The ETF sold 392 shares of ISRG on 2025-06-10. The shares were previously bought for an average price of USD 541.1. The Intuitive Surgical Inc shares were sold for -2.1% lower than average price of previous purchases. This resulted in an overall loss of USD 4,508 The average price that the ETF previously sold ISRG share for is USD 531.24 which is higher than the selling price of USD 529.6 on 2025-06-10. |
| MRK - Marks Electrical Group PLC | SELL | -2,798 @ USD 81.35 | USD -227,617 | The ETF sold 2798 shares of MRK on 2025-06-10. The shares were previously bought for an average price of USD 91.8712. The Marks Electrical Group PLC shares were sold for -11.5% lower than average price of previous purchases. This resulted in an overall loss of USD 29,438 The average price that the ETF previously sold MRK share for is USD 97.7671 which is higher than the selling price of USD 81.35 on 2025-06-10. |
| MRK - Merck & Company Inc | SELL | -2,798 @ USD 81.35 | USD -227,617 | The ETF sold 2798 shares of MRK on 2025-06-10. The shares were previously bought for an average price of USD 91.8712. The Merck & Company Inc shares were sold for -11.5% lower than average price of previous purchases. This resulted in an overall loss of USD 29,438 The average price that the ETF previously sold MRK share for is USD 97.7671 which is higher than the selling price of USD 81.35 on 2025-06-10. |
| ABT - Abbott Laboratories | SELL | -1,918 @ USD 134.13 | USD -257,261 | The ETF sold 1918 shares of ABT on 2025-06-10. The shares were previously bought for an average price of USD 127.034. The Abbott Laboratories shares were sold for 5.6% higher than average price of previous purchases. This sale made a profit of USD 13,610 The average price that the ETF previously sold ABT share for is USD 118.397 so the ETF has sold 1918 shares on 2025-06-10 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -1,014 @ USD 303.79 | USD -308,043 | The ETF sold 1014 shares of UNH on 2025-06-10. The shares were previously bought for an average price of USD 524.136. The UnitedHealth Group Incorporated shares were sold for -42.0% lower than average price of previous purchases. This resulted in an overall loss of USD 223,431 The average price that the ETF previously sold UNH share for is USD 546.551 which is higher than the selling price of USD 303.79 on 2025-06-10. |
| ABBV - AbbVie Inc | SELL | -1,942 @ USD 189.5 | USD -368,009 | The ETF sold 1942 shares of ABBV on 2025-06-10. The shares were previously bought for an average price of USD 193.556. The AbbVie Inc shares were sold for -2.1% lower than average price of previous purchases. This resulted in an overall loss of USD 7,877 The average price that the ETF previously sold ABBV share for is USD 185.103 so the ETF has sold 1942 shares on 2025-06-10 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -2,646 @ USD 156.45 | USD -413,967 | The ETF sold 2646 shares of JNJ on 2025-06-10. The shares were previously bought for an average price of USD 157.979. The Johnson & Johnson shares were sold for -1.0% lower than average price of previous purchases. This resulted in an overall loss of USD 4,046 The average price that the ETF previously sold JNJ share for is USD 152.623 so the ETF has sold 2646 shares on 2025-06-10 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -860 @ USD 807.19 | USD -694,183 | The ETF sold 860 shares of LLY on 2025-06-10. The shares were previously bought for an average price of USD 837.646. The Eli Lilly and Company shares were sold for -3.6% lower than average price of previous purchases. This resulted in an overall loss of USD 26,192 The average price that the ETF previously sold LLY share for is USD 792.847 so the ETF has sold 860 shares on 2025-06-10 at a higher price than the previous selling average. |